Introduction
============

Invasive pulmonary aspergillosis generally occurs in patients with severe immunodeficiency and can be a major cause of morbidity and mortality ([@B1]). Aspergillus osteomyelitis is a debilitating and severe form of invasive aspergillosis, but it is extremely rare with a high mortality rate ([@B2],[@B3]). Vinas et al. ([@B4]) and Studemeister et al. ([@B5]) reviewed the literature on 41 and 21 previous aspergillus vertebral osteomyelitis cases, respectively. However, only Japanese reports of vertebral aspergillosis cases have been published, and we found none of these Japanese case reports in the English literature. We searched PubMed and Japana Centra Revuo Medicina (Igaku-Chuo-Zasshi), which is a database for Japanese medical journals, to identify case reports of vertebral aspergillosis in Japan and found 27 cases reported from 1972 to 2017 ([@B6]-[@B31]).

We herein report a rare case of invasive pulmonary aspergillosis spreading to the epidural space in a patient with acute myelogenous leukemia with myelodysplasia-related changes (AML/MRC). Previously reported cases of vertebral aspergillosis in Japan were also reviewed and summarized.

Case Report
===========

A 70-year-old Japanese woman presented with a fever and chronic cough that had developed 1 week before admission. She had been diagnosed with nontuberculous mycobacteriosis of *Mycobacterium avium* and bronchiectasis with chronic cough at 30 years of age and AML/MRC 20 months earlier. She was subsequently treated with a cycle of low-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor (CAG regimen) along with 15 cycles of azacitidine regimen. The azacitidine regimen had been performed seven days earlier, and a slight fever was noted. Her familial history was unremarkable.

The patient was slightly drowsy upon arrival, but her Glasgow Coma Score was 15. Her blood pressure, pulse, body temperature, and respiratory rate were 84/53 mmHg, 92 beats/min, 37.1°C, and 22 cycles/min, respectively. Her height and weight were 156.0 cm and 36.8 kg, respectively. A physical examination revealed conjunctival pallor, furry tongue, generalized purpura, and coarse crackles at the right upper lobe. Her extremities were warm. Laboratory studies demonstrated pancytopenia and elevation of C-reactive protein (CRP) levels. In addition, serum β-D-glucan (measured by the kinetic colorimetric assay called Fungitec G-Test MK) and aspergillus antigen levels were elevated ([Table 1](#t001){ref-type="table"}). A sputum culture was only positive for *Staphylococcus epidermidis*, which is a normal flora species.

###### 

Summary of Laboratory Data upon Admission.

  ------------ ------ ----------------- -- ------------------------------------------- ------- -------
  Hematology          Blood chemistry                                                          
  WBC          100    /μL                  TP                                          5.1     g/dL
  Neutro       14.3   \%                   Alb                                         2.0     g/dL
  Lym          78.6   \%                   AST                                         12      U/L
  Mono         7.1    \%                   ALT                                         40      U/L
  RBC          255    10^4^/μL             LDH                                         116     U/L
  Hb           7.4    g/dL                 ALP                                         621     U/L
  Ht           21.5   \%                   T-Bil                                       1.1     mg/dL
  MCV          84.3   fL                   BUN                                         21.4    mg/dL
  Plt          0.6    10^4^/μL             Cre                                         0.66    mg/dL
                                           Na                                          133     mEq/L
                                           K                                           3.4     mEq/L
                                           Cl                                          97      mEq/L
                                           Ca                                          8.8     mg/dL
                                           Mg                                          1.7     mg/dL
                                           IP                                          4.0     mg/dL
                                           Ferritin                                    4,371   ng/mL
                                           CRP                                         34.3    mg/dL
                                           Procalcitonin                               9.2     ng/mL
                                           β-D-glucan                                  36.5    pg/mL
                                           Aspergillus antigen (cutoff index; 0-0.4)   0.5     
  ------------ ------ ----------------- -- ------------------------------------------- ------- -------

WBC: white blood cells, Neutro: neutrophils, Lym: lymphocytes, Mono: monocytes, RBC: red blood cells, Hb: hemoglobin, Ht: hematocrit, MCV: mean cell volume, Plt: platelets, TP: total protein, Alb: albumin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: Alkaline phosphatase, T-Bil: total bilirubin, BUN: blood-urea-nitrogen, Cre: creatinine, CRP: C-reactive protein

Chest roentgenogram and computed tomography (CT) of the chest showed consolidation with lesions in right S3 and S6 and left S3, S4, and S6 ([Fig. 1](#g001){ref-type="fig"}, [2](#g002){ref-type="fig"}). The right S6 lesion was located at the level of the T5 vertebra. The patient was initially diagnosed with febrile neutropenia, bilateral pneumonia, and oral candida infection, which were treated with the granulocyte-colony stimulating factor cefepime (CFPM) 4 g/day and liposomal amphotericin B (L-AMB) 2.5 mg/kg/day. On day 2,*Pseudomonas aeruginosa* was detected in the patient's blood culture, and the fever had not abated. Antibiotic therapy was escalated to meropenem (MEPM) 3 g/day based on the results of the antibiogram on day 4. However, on the same day, she complained of right lower leg weakness, although she was able to walk. On day 6, she developed right hemiplegia and left thermal hypoalgesia in the T6 level, presenting as Brown-Sequard syndrome-like symptoms.

![Chest roentgenogram showing bilateral infiltrations.](1349-7235-57-3205-g001){#g001}

![Computed tomography image of the chest showing the consolidation with lesions at the right upper and lower lobe, left lingular lobe, and lower lobe (red arrows).](1349-7235-57-3205-g002){#g002}

Her brain CT findings were unremarkable. Magnetic resonance imaging (MRI) of the thoracic and lumbar spine showed that consolidation was contiguously spreading toward the epidural space at the level between the T4 and T5 ([Fig. 3](#g003){ref-type="fig"}). Although radiological findings demonstrated discitis, osteomyelitis, and an epidural mass at the same levels, the patient was not given surgical treatment due to her poor condition. On day 7, the patient developed paraplegia, absent bilateral lower tendon reflexes, and bladder and rectal disturbance; thus, contrast CT of the chest and abdomen was performed ([Fig. 4](#g004){ref-type="fig"}). The results showed bilateral hydronephrosis, intestinal gas accumulation, and an infiltrative epidural tumor secondary to pulmonary consolidation. We immediately performed CT-guided thoracentesis from the back to examine the tumor in right S6 ([Fig. 5](#g005){ref-type="fig"}), and cytology of the right pleural effusion and the mass detected the presence of *Aspergillus fumigatus*, which was confirmed based on the morphology and real-time polymerase chain reaction for *A. fumigatus* DNA (geniQ^Ⓡ^; KITASATO-OTSUKA Biomedical Assay Laboratories Company, Sagamihara, Japan) (5,000 copies/mL, normal range: \<40 copies/mL) ([Fig. 6](#g006){ref-type="fig"}).

![Magnetic resonance imaging of the thoracic and lumbar spine showing the consolidation (red arrows) contiguously spreading toward the epidural space at the level of T4 and T5: (a) T1-weighted image on an axial view. (b) T1-weighted image on a sagittal view. (c) T2-weighted image on an axial view. (d) T2-weighted image on a coronal view.](1349-7235-57-3205-g003){#g003}

![Contrast CT of the chest and abdomen showing bilateral hydronephrosis (a, c), intestinal gas accumulation (b), and the epidural mass (d).](1349-7235-57-3205-g004){#g004}

![CT-guided thoracentesis from the back into the mass in right S6.](1349-7235-57-3205-g005){#g005}

![The results of cytology of patient's pleural effusion showing *Aspergillus fumigatus* (left: Papanicolaou stain, right: Grocott's methenamine silver stain; ×1,000).](1349-7235-57-3205-g006){#g006}

A diagnosis of vertebral aspergillosis was made, so micafungin (MCFG) 200 mg/day was added, and the dose of L-AMB was increased to 4.0 mg/kg/day on day 8. On day 9, drainage tubes were inserted under CT-guided thoracentesis, and saline perfusion was also performed using drainage tubes. Intravenous voriconazole (VRCZ) 6 mg/kg was administered every 12 hours on day 10 instead of L-AMB and MCFG and subsequently decreased to 4 mg/kg twice daily, but the patient died 14 days after hospital admission due to uncontrolled infection and multiple organ failure, including disseminated intravascular coagulation. During the hospitalization, the patient's pancytopenia, elevated CRP, and fever never improved ([Fig. 7](#g007){ref-type="fig"}). Catheter tip cultures of drainage tubes were also positive for *A. fumigatus*.

![The clinical course of the patient. CFPM: Cefepime, CRP: C-reactive protein, L-AMB: Liposomal amphotericin B, MCFG: Micafungin, MEPM: Meropenem, VRCZ: Voriconazole](1349-7235-57-3205-g007){#g007}

Discussion
==========

*Aspergillus* spp. have emerged as major causes of morbidity and mortality in immunocompromised hosts. Patients with osteomyelitis caused by *Aspergillus* spp. had an overall mortality rate of 25% ([@B2]). However, patients with vertebral osteomyelitis had lower mortality rates ([@B4]). The major clinical features of the 27 previously reported cases of vertebral aspergillosis in Japan and our case are summarized in [Table 2](#t002){ref-type="table"} ([@B6]-[@B31]).

###### 

Literature Review of Vertebral Aspergillosis Reported in Japan.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case   Reference/\           Age\      Sex   *Aspergillus*\   Presentation                                      Predisposing factor(s)                                                           Infectious route                       Paralysis   Spine\    Radiological\                            Antifungal\          Surgical treatment                               Outcome
         year                  (years)         species                                                                                                                                                                                                level     finding(s)                               treatment                                                             
  ------ --------------------- --------- ----- ---------------- ------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------- ----------- --------- ---------------------------------------- -------------------- ------------------------------------------------ ---------
  1      \[6\], 1972           38        F     *fumigatus*      Neck pain, back pain                              Tuberculosis, empyema, pulmonary aspergillosis                                   ND                                     No          C5-L2     Discitis, osteomyelitis                  ND                   Posterior spinal fusion                          Alive

  2      \[7\], 1978           53        M     ND               Chest pain, fever                                 Tuberculosis, steroid user                                                       Contiguous spread                      Yes         T3-T7     Discitis, osteomyelitis, epidural mass   ND                   Laminectomy                                      Death

  3      \[8\], 1981           57        M     *fumigatus*      Chest pain, back pain                             Tuberculosis (lobectomy)                                                         Hematogenous                           No          C6-L3     Discitis, osteomyelitis                  AMPH-B               None                                             Alive

  4      \[9\], 1987           62        M     *fumigatus*      Back pain                                         Tuberculosis                                                                     Contiguous spread                      Yes         T6-T7     Epidural mass                            AMPH-B, 5-FC         Laminectomy                                      Death

  5      \[10\], 1989          13        M     *fumigatus*      Back pain                                         Chronic granulomatous disease                                                    Contiguous spread                      Yes         C6-T4     Discitis, osteomyelitis, epidural mass   ND                   Anterior spinal fusion, debridement              Death

  6      \[11\], 1991          71        M     ND               Lower extremity weakness                          Tuberculosis, alcoholic liver failure                                            Contiguous spread                      Yes         T4-T5     Epidural mass                            ND                   Laminectomy                                      Death

  7      \[12\], 1992          71        M     *fumigatus*      Chest pain, back pain, lower extremity weakness   Tuberculosis, alcoholic liver failure                                            Contiguous spread                      Yes         T4        Epidural mass                            MCZ                  Laminectomy                                      Death

  8      \[13\], 1992          63        M     *fumigatus*      Lower extremity weakness, incontinence            Tuberculosis, pulmonary aspergillosis                                            Contiguous spread                      Yes         T2-T5     Discitis, osteomyelitis, epidural mass   MCZ                  None                                             Death

  9      \[14\], 1994          56        M     ND               Lower extremity weakness, back pain               Lung cancer (lobectomy+radiation)                                                Contiguous spread                      Yes         T3-T5     Osteomyelitis, epidural mass             FLCZ                 Posterior spinal fusion                          Death

  10     \[15\], 1995          47        F     ND               Low back pain                                     Acute lymphocytic leukemia (chemotherapy, steroid user)                          Hematogenous                           No          L4-S1     Discitis                                 AMPH-B, MCZ          Laminectomy, debridement                         Alive

  11     \[16\], 1996          53        F     *fumigatus*      Chest pain, extremity weakness                    Tuberculosis                                                                     Contiguous spread                      Yes         T5        Osteomyelitis, epidural mass             ND                   None                                             Death

  12     \[17\], 1997          53        M     *fumigatus*      Back pain, lower extremity weakness, dysuria      Tuberculosis (thoracoplasty)                                                     Hematogenous                           Yes         T11-L2    Discitis, osteomyelitis, epidural mass   AMPH-B, FLCZ         Laminectomy, debridement                         Alive

  13     \[18\], 1998          8         F     ND               Lower extremity weakness, dysuria, back pain      Chronic granulomatous disease, pneumonia                                         Contiguous spread                      Yes         T2-T5     Epidural mass, osteomyelitis, discitis   ITCZ, FLCZ, AMPH-B   Laminectomy                                      Death

  14     \[19\], 1998          41        F     ND               Back pain, lower extremity numbness               Acute lymphocytic leukemia                                                       Hematogenous                           Yes         L4-S1     Osteomyelitis, epidural mass             AMPH-B               Laminectomy, debridement                         Alive

  15     \[19\], 1998          54        F     *fumigatus*      Back pain, lower extremity weakness               Thrombocytopenic purpura, steroid user                                           Contiguous spread                      Yes         T7-T9     Discitis, osteomyelitis, epidural mass   ND                   None                                             Death

  16     \[20\], 2000          70        M     ND               Right lower extremity weakness, back pain         Acute lymphocytic leukemia                                                       Contiguous spread                      Yes         ND        Osteomyelitis                            ND                   None                                             Death

  17     \[21\], 2000          67        M     ND               Low back pain, lower extremity pain               Tuberculosis (thoracoplasty)                                                     Hematogenous                           Yes         T11-L2    Osteomyelitis, epidural mass             ND                   Laminectomy, debridement                         Death

  18     \[22\], 2000          68        M     ND               Lower extremity weakness                          Traumatic pleurisy (thoracoplasty), diabetes mellitus, pulmonary aspergillosis   ND                                     Yes         T9-T10    Discitis,epidural mass                   FLCZ, AMPH-B         Costotransversectomy, laminectomy, debridement   Alive

  19     \[23\], 2003          61        M     ND               Lower extremity weakness                          ND                                                                               ND                                     Yes         T6-T7     Discitis, osteomyelitis, epidural mass   ND                   Laminectomy, debridement                         Death

  20     \[24\], 2003          75        F     ND               Lower extremity weakness                          Immune thrombocytopenic purpura, steroid user, diabetes mellitus                 Hematogenous                           Yes         T10       Epidural mass, compression fracture      FLCZ, ITCZ           Laminectomy, debridement                         Alive

  21     \[25\], 2007          77        M     ND               Lower extremity weakness, dysuria                 Lung cancer (lobectomy+radiation), pulmonary aspergillosis                       Contiguous spread                      Yes         T3-T4     Discitis, osteomyelitis, epidural mass   VRCZ, MCFG           Laminectomy, posterior spinal fusion             Alive

  22     \[26\], 2009          64        M     *fumigatus*      Lower extremity weakness                          Retrobulbar optic neuritis, steroid user, hepatitis C                            Hematogenous                           Yes         T8-T9     Discitis, osteomyelitis, epidural mass   VRCZ, AMPH-B         None                                             Death

  23     \[27\], 2012          70        F     ND               Low back pain                                     Neutropenia, steroid user                                                        Hematogenous                           No          L4-L5     Discitis                                 VRCZ                 Discectomy                                       Alive

  24     \[28\], 2013          60        M     ND               Chest pain, back pain, extremity weakness         Lung cancer (lobectomy+radiation), pulmonary aspergillosis                       Contiguous spread                      Yes         Spine     Osteomyelitis, epidural mass             MCFG, L-AMB          Laminectomy, debridement                         Death

  25     \[29\], 2013          60        M     ND               Right lower extremity weakness                    Lung cancer (lobectomy+radiation), pulmonary aspergillosis                       Contiguous spread                      Yes         T5-T6     Epidural mass                            ND                   Laminectomy, debridement                         Death

  26     \[30\], 2015          73        M     ND               Back pain                                         Lung cancer (radiation), pulmonary aspergillosis                                 Contiguous spread                      No          T2        Osteomyelitis                            VRCZ, MCFG           None                                             Alive

  27     \[31\], 2017          72        M     ND               Low back pain, muscle weakness                    Open vertebral fracture (Th12; debridement)                                      Direct inoculation (wound infection)   Yes         T11-T12   Discitis                                 ND                   Anterior spinal fusion                           Alive

  28     Ono (our case) 2018   70        F     *fumigatus*      Fever, lower extremity weakness                   AML/MRC, nontuberculous mycobacteriosis, bronchiectasis, steroid user            Contiguous spread                      Yes         T4-T5     Discitis, osteomyelitis, epidural mass   VRCZ, MCFG           None                                             Death
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ND: Not described, MCZ: Miconazole, MCFG: Micafungin, L-AMB: Liposomal amphotericin B, VRCZ: Voriconazole, AMPH-B: Amphotericin B, ITCZ: Itraconazole, FLCZ: Fluconazole, 5-FC: 5-Fluorocytosine

The mean age of the population ± standard deviation was 58.1 ± 16.4 years (range, 8-77 years), of which 19 were men and 9 women. Young patients with chronic granulomatous disease were described in two cases out of the 28 cases of vertebral aspergillosis. *A. fumigatus* was detected in 11 cases (39%), but the *Aspergillus* spp. detected in the other cases were not described in detail. The most common presenting symptom of vertebral aspergillosis was extremity weakness (68%), followed by back pain (61%), chest pain (18%), urinary problems such as incontinence or dysuria (14%), a fever (7%), and neck pain (4%). Throughout the process, neurological deficit as a sign of paralysis was finally noted in 23 cases (82%).

Causes of vertebral aspergillosis can be divided into three main categories. Direct inoculation related to trauma, spinal surgery, or epidural injection occurs rarely and manifests generally within months after the procedure, while contiguous spread from pulmonary disease mainly affects the thoracic spine. Hematogenous infection occurs generally in immunosuppressed patients. A previous study reported that about half of patients acquired the infection by a presumed hematogenous route ([@B5]). However, in Japan, 16 cases (57%) acquired the infection by a presumed contiguous spread. This is due to the high prevalence of tuberculosis and lung cancer in Japan, which is a tuberculosis middle-burden country ([@B32]). Our study reported 10 cases of tuberculosis (36%) and 5 cases of lung cancer with surgical and radiation treatment (18%) as predisposing factors, respectively. Usually, patients with chronic lung disease are prone to *Aspergillus* colonization and infection. Patients infected with nontuberculous mycobacteriosis may have coexisting lung disease, such as bronchiectasis or chronic obstructive pulmonary disease. Although our case had a history of nontuberculous mycobacteriosis and bronchiectasis, a recent study showed that patients with bronchiectasis and nontuberculous mycobacterial disease have a higher prevalence of coexisting *Aspergillus*-related lung disease than those with bronchiectasis and without nontuberculous mycobacteria ([@B33]). Therefore, nontuberculous mycobacterial disease or bronchiectasis should be considered risk factors for vertebral aspergillosis. The hematogenous spread was observed in 8 cases (29%), but only 1 (4%) of these cases was due to wound infection by direct inoculation.

The thoracic vertebrae were the most frequent sites of infection (82.1%), while the lumbar vertebrae and cervical spine were involved in 25.0% and 10.7% of the cases, respectively. The thoracic vertebrae are easily affected by contiguous spread arising from pulmonary diseases. Most patients presented with discitis or osteomyelitis at one or more levels of the cervical, thoracic, or lumbar spine. Epidural mass was reported in 21 cases (75%). Since the radiological findings are nonspecific, the definitive diagnosis of vertebral aspergillosis requires the isolation of the organism from bone specimens obtained by a needle biopsy or open biopsy or from aspirate of adjacent fluid collection ([@B4]). Our study suggested that CT-guided thoracentesis may be an effective way of obtaining specimens.

A total of 17 patients (61%) were treated with antifungal agents, while 20 patients (71%) received surgical treatments. The overall mortality rate was 61%, and the recovery rate was 39%. About 7 of the 11 patients who survived from vertebral aspergillosis were given both surgical and antifungal treatments. The penetration of antifungal agents in bone tissues is controversial. Denes et al. reported VRCZ may have a role in managing infection at the bone since the concentration of the VRCZ was high in the bone ([@B34]). However, the amphotericin concentrations were found to be high in the bone marrow of dogs and rabbits following the administration of any of the currently available formulations, including L-AMB. No data are available for MCFG, although this has been used to treat a few patients with bone/joint infections, in combination with amphotericin ([@B35]).

In summary, our review of reported cases of vertebral aspergillosis in Japan suggested that patients with a history of pulmonary diseases such as tuberculosis, including nontuberculous mycobacteriosis, bronchiectasis, or lung cancer treated with surgery or radiology, should be screened for aspergillosis. If such patients develop extremity weakness or back pain, MRI of the spine should be performed to diagnose vertebral aspergillosis. CT-guided thoracentesis should be considered in order to identify the cytology. Antifungal therapy in combination with surgical treatment should be given to treat serious and life-threatening infections as the condition allows.
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